4//SEC Filing
Dye Justin 4
Accession 0001104659-22-119652
CIK 0001622879other
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 8:56 PM ET
Size
10.3 KB
Accession
0001104659-22-119652
Insider Transaction Report
Form 4
Dye Justin
Director
Transactions
- Award
Common Stock
2022-11-16$1.80/sh+106,500$191,700→ 584,952 total - Award
Common Stock
2022-11-14$1.31/sh+142,258$186,358→ 290,968 total - Award
Common Stock
2022-11-15$1.57/sh+187,484$294,350→ 478,452 total
Holdings
- 9,287,500(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $1.13 to $1.43 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $1.34 to $1.74 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F3]The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $1.68 to $1.86 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F4]Represents shares of common stock held by Dye Capital & Company, LLC ("Dye Capital"). As the general partner of Dye Capital, Mr. Dye has voting and investment control over the securities held by Dye Capital. Mr. Dye disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein.
Documents
Issuer
Medicine Man Technologies, Inc.
CIK 0001622879
Entity typeother
Related Parties
1- filerCIK 0001654539
Filing Metadata
- Form type
- 4
- Filed
- Nov 15, 7:00 PM ET
- Accepted
- Nov 16, 8:56 PM ET
- Size
- 10.3 KB